| PERIOD ENDING | 30-Sep-09 | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | | Total Revenue | 36,556 | 33,291 | 34,334 | 35,506 | | Cost of Revenue | 15,438 | 14,413 | 15,336 | 16,044 | | | Gross Profit | 21,118 | 18,878 | 18,998 | 19,462 | | | Operating Expenses | | Research Development | 4,090 | 4,742 | 5,237 | 5,423 | | Selling General and Administrative | 12,173 | 11,792 | 12,770 | 13,810 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 3,306 | 3,589 | 3,948 | 4,436 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 1,549 | (1,245) | (2,957) | (4,207) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 221 | (54) | 591 | 172 | | Earnings Before Interest And Taxes | 1,770 | (1,299) | (2,366) | (4,035) | | Interest Expense |
-
|
-
| (24) | 24 | | Income Before Tax | 1,770 | (1,299) | (2,342) | (4,059) | | Income Tax Expense | 598 | 671 | 527 | (210) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 1,172 | (1,970) | (2,869) | (3,849) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 1,172 | (1,970) | (2,869) | (3,849) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $1,172 | ($1,970) | ($2,869) | ($3,849) |
|
0.51% Nasdaq 
Income Statement
